Compounds > c.i. 42510
Page last updated: 2024-08-21

c.i. 42510 and Peritoneal Carcinomatosis

c.i. 42510 has been researched along with Peritoneal Carcinomatosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, KC; Wu, CC; Yang, BL1
Abbaci, M; Dartigues, P; De Leeuw, F; Fabre, M; Laplace-Builhé, C; Soufan, R1
Beltramo, JL; Benoit, L; Brunet-Lecomte, P; Chauffert, B; Correia, M; Duvillard, C; Moretto, P; Sergent, C1

Other Studies

3 other study(ies) available for c.i. 42510 and Peritoneal Carcinomatosis

ArticleYear
Preoperative computerized tomography-guided blue dye localization for metastatic lymphadenopathy and peritoneal tumor implants during laparoscopic surgery: Two case reports.
    Medicine, 2019, Volume: 98, Issue:25

    Topics: Abdomen; Coloring Agents; Female; Humans; Laparoscopy; Lymphadenopathy; Middle Aged; Peritoneal Neoplasms; Rosaniline Dyes; Tomography, X-Ray Computed

2019
Patent blue V and indocyanine green for fluorescence microimaging of human peritoneal carcinomatosis using probe-based confocal laser endomicroscopy.
    Surgical endoscopy, 2016, Volume: 30, Issue:12

    Topics: Adult; Aged; Female; Fluorescence; Fluorescent Dyes; Humans; Indocyanine Green; Male; Microscopy, Confocal; Microsurgery; Peritoneal Neoplasms; Rosaniline Dyes

2016
Epinephrine enhances penetration and anti-cancer activity of local cisplatin on rat sub-cutaneous and peritoneal tumors.
    International journal of cancer, 1999, May-31, Volume: 81, Issue:5

    Topics: Animals; Antineoplastic Agents; Cisplatin; Coloring Agents; Drug Synergism; Drug Therapy, Combination; Epinephrine; Female; Injections; Peritoneal Neoplasms; Rats; Rats, Inbred Strains; Rosaniline Dyes; Skin Neoplasms; Spectrometry, X-Ray Emission; Survival Rate; Tumor Cells, Cultured; Vasoconstrictor Agents

1999